Connective tissue growth factor (CTGF) has been suggested as a tumor suppressor in human breast cancer [27] and the secretory leukocyte protease inhibitor (SLPI) that enhances tumor aggressiveness through vascular mimicry [28]. The gene discussed is SLPI; the disease is neoplasm.